Showing 3281-3290 of 10618 results for "".
Retinal Vein Occlusion in Younger Patients: Key Care Considerations
https://reachmd.com/programs/eye-on-ocular-health/retinal-vein-occlusion-in-younger-patients-key-care-considerations/54491/Retinal vein occlusion in younger patients is important to pay attention to, especially because it may be a signal of a blood clotting disorder. Join Dr. Jessica Randolph, Assistant Professor at Virginia Commonwealth University and a practicing vitreoretinal surgeon at Wagner Kapoor Institute in RicBridging the Gap Between Vaccine Access and Delivery
https://reachmd.com/programs/on-the-frontlines-of-immunizations/bridging-the-gap-between-vaccine-access-and-delivery/56695/Inconsistent vaccine delivery across care settings can delay immunization and lead to missed opportunities for protection—which means that when vaccines aren’t readily available at the point of care, even motivated patients may fall through the cracks. Joining Dr. Alexandria May to explore these chaA Personalized Approach to Complex Psoriasis Cases
https://reachmd.com/programs/frontlines-psoriasis/personalized-approach-complex-psoriasis/39955/Evolving insights into Th1-, Th2-, and Th17-driven inflammation are reshaping the diagnosis and management of patients presenting with mixed psoriasis subtypes. Ryan Quigley sits down with Dr. Jenny Murase to learn more about practical approaches to personalized treatment planning, common clinical pThe Role of Systemic Steroids in Atopic Dermatitis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37139/Practical Dermatology Editorial Board member Todd Schlesinger, MD, a board-certified dermatologist and Mohs surgeon with Epiphany Dermatology in Charleston, South Carolina, discusses the role of systemic steroids in treating atopic dermatitis.Integrating CMR and Genetics to Improve ATTR-CM Diagnosis
https://reachmd.com/programs/Audioabstracts/cardiac-mri-genetics-attr-cm-diagnosis/49066/An April 2025 Current Cardiology Reports article provides new insights into the role of cardiac magnetic resonance (CMR) and genetic data in diagnosing hereditary transthyretin amyloid cardiomyopathy (ATTR-CM). Learn more about this potential approach with Ryan Quigley in this AudioAbstract.Challenging the Status Quo in Schizophrenia Treatment
https://reachmd.com/programs/frontlines-schizophrenia/challenging-status-quo-schizophrenia/54154/Schizophrenia care is at a turning point. As novel therapies and psychosocial interventions begin to challenge long-standing approaches, clinicians and patients are looking forward to a future of optimized care and improved long-term outcomes. Tune in to hear Dr. Stephen Marder in conversation withUnderstanding the Skin–Mind Connection in Neurocosmetics
https://reachmd.com/ma-issues-index/march-april-2026-issue/understanding-the-skinmind-connection-in-neurocosmetics/56636/Neurocosmetics tap the skin–brain axis to influence both cutaneous function and emotional well-beingAdvancing Relapse Prediction in Pediatric AML Through Genomic MRD
https://reachmd.com/programs/clinicians-roundtable/relapse-prediction-pediatric-aml-genomic-mrd/54352/Emerging research suggests genomic minimal residual disease (MRD) could be a more sensitive and stable approach to predicting relapse in pediatric acute myeloid leukemia (AML). Ryan Quigley sits down with Dr. Amanda Winters to learn more about how this method could aid in earlier interventioCommitment to Clinical Evidence in Regenerative Aesthetics
https://reachmd.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/Laura Ellis, MD, CEO and Co-Founder of LevEllis, Inc., discusses the current state of aesthetic regenerative medicine and the importance of clinical evidence as the field continues to advance.Face Value with Modern Aesthetics: Inside South Korea’s Aesthetic Boom
https://reachmd.com/series/face-value/face-value-with-modern-aesthetics-inside-south-koreas-aesthetic-boom/49020/In the latest episode, Dr. Lanna Cheuck speaks about her recent trip to South Korea and what it reveals about the future of aesthetics medicine. She explores the rise of high-volume, technology-driven clinics, differences in practice models, and how innovation in regenerative injectables and stacked